BioCorRx Inc., an Anaheim-based substance abuse treatment program maker, has promoted Lourdes Felix to chief executive.
Felix joined BioCorRx in 2012 as chief financial officer and will continue in both roles.
She succeeds Brady Grainer, who was named president. He will continue to lead the company’s pharmaceuticals subsidiary, which is preparing to take its lead candidate through phase 1 clinical trials.
